New once-daily Hep C treatment recommended for PBS

liver cancer: "liver" spelled out on post-its hanging from line
The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has registered a new treatment for the treatment of chronic hepatitis C infection in adults. The PBAC has also recommended EPCLUSA (sofosbuvir/velpatasvir) for listing on the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous APP2017 welcomes back Malcolm Scrymgeour
Next The reason behind skyrocketing autism rates